e-learning
resources
Amsterdam 2015
Wednesday, 30.09.2015
Cellular and molecular mechanisms of COPD and emphysema
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Identification and characterization of mesenchymal stem cells in the human lung
Tamara Cruz (Barcelona, Spain), Tamara Cruz, Alejandra Lopez, Alvar Agusti, Rosa Faner
Source:
International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Session:
Cellular and molecular mechanisms of COPD and emphysema
Session type:
Poster Discussion
Number:
5059
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Tamara Cruz (Barcelona, Spain), Tamara Cruz, Alejandra Lopez, Alvar Agusti, Rosa Faner. Identification and characterization of mesenchymal stem cells in the human lung. Eur Respir J 2015; 46: Suppl. 59, 5059
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Impaired migration of bone marrow mesenchymal stem cells in COPD
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Generation of an immortalized functional alveolar epithelial cell line originating from human induced pluripotent stem cells
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016
The secretome of induced pluripotent stem cells (iPSC) modulates macrophage phenotype in the fibrotic lung
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Characterization of human mesenchymal stem cells phenotype and secretome in a in vitro model of acute lung injury inflammation
Source: Annual Congress 2011 - Lung cell injury and repair
Year: 2011
Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells
Source: Eur Respir J 2012; 39: 446-457
Year: 2012
Myeloid derived suppressor cell-like fibrocytes are increased and associated with preserved lung function in COPD
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
In search of ckit+ stem cells in lung tissue
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
Effects of autologous mesenchymal stromal cell treatment for severe emphysema on lung tissue: A clinical trial
Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease
Year: 2015
Pluripotent stem cells isolated from adult human lung tissue exhibit anti-fibrotic properties
Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung
Year: 2013
LSC - 2021 - Role of mitochondrial function of lung mesenchymal stem cells in idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021
Epithelial mesenchymal transition (EMT) in the small and large airways of lung cancer patients undergoing thoracotomy
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease
Source: Eur Respir Monogr 2021; 91: 205-221
Year: 2021
Modelling human lung development and disease using pluripotent stem cells
Source: International Congress 2015 – Regenerative medicine of the lung: opportunities and threats
Year: 2015
LSC Abstract – Network analysis of induced pluripotent stem cells secretome reveales its anti fibrotic action in rat lung injury model
Source: International Congress 2016 – New therapies and therapeutic targets
Year: 2016
Epithelial to mesenchymal transition in basal progenitor epithelial cells cultured from smokers and COPD patients
Source: International Congress 2015 – Airway remodelling: recent developments
Year: 2015
Fibrosis-specific stem-like cells in peripheral IPF lung: Characteristics and potential role
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020
Different stages of wound repair in differentiated human bronchial epithelial cells show altered microRNA expression
Source: International Congress 2015 – Airway remodelling: recent developments
Year: 2015
Functional and molecular disparities between mesenchymal stem cells from various pulmonary disorders
Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells
Year: 2014
Progress towards human lung regeneration in end-stage respiratory failure: studying human lung development in vitro using organoid cultures of human embryonic lung stem cells
Source: International Congress 2018 – Cell-matrix interactions in lung disease and regeneration
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept